VALNEVA (EPA:VLA) | WebDisclosure

PRESS RELEASE

published on 08/13/2024 at 07:00, 3 months 10 days ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
Valneva reports first-half 2024 financial results as total revenues reach €70.8 million with net profit of €34.0 million. Company confirms full-year guidance and updates strategic pipeline expansion

Revenues Financial Results Net Profit Valneva Strategic Pipeline
BRIEF

published on 08/06/2024 at 08:35, 3 months 17 days ago

Valneva annonce des modifications au titre du capital et des droits de vote au 31 juillet 2024

Euronext Paris Actions Biopharmaceutique Droit De Vote Valneva
BRIEF

published on 08/06/2024 at 08:35, 3 months 17 days ago

Valneva Announces Share and Voting Right Changes as of July 31, 2024

Euronext Paris Voting Rights Shares Biopharmaceutical Valneva
PRESS RELEASE

published on 08/06/2024 at 08:30, 3 months 17 days ago

VALNEVA - Déclaration d’actions et de droits de vote : 31 juillet 2024
Déclaration d'actions et de droits de vote de Valneva pour le 31 juillet 2024. Cession et passages de titres avec droits de vote double

Cession Droits De Vote Actions Valneva Double
PRESS RELEASE

published on 08/06/2024 at 08:30, 3 months 17 days ago

VALNEVA - Declaration of shares and voting rights: July 31, 2024
VALNEVA declared changes in shares and voting rights including sale, transfer, and granting of double voting rights on various dates

Voting Rights Shares Sale Transfer Valneva
BRIEF

published on 07/17/2024 at 22:05, 4 months 5 days ago

Essai de Phase 3 VALOR : Valneva et Pfizer finalisent la vaccination primaire contre la maladie de Lyme

Essai Clinique Valneva Pfizer VLA15 Lyme
BRIEF

published on 07/17/2024 at 22:05, 4 months 5 days ago

VALOR Phase 3 Trial: Valneva and Pfizer Finalize Primary Lyme Disease Vaccination

Clinical Test Valneva Pfizer VLA15 Lyme
PRESS RELEASE

published on 07/17/2024 at 22:00, 4 months 5 days ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
PRESS RELEASE

published on 07/17/2024 at 22:00, 4 months 5 days ago

Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants
Pfizer et Valneva finalisent la vaccination primaire de l'essai de Phase 3 VALOR contre la maladie de Lyme, avec VLA15. Suivi des participants pour mesurer l'incidence de la maladie

Valneva Maladie De Lyme Pfizer Phase 3 VALOR Vaccination Primaire
BRIEF

published on 06/05/2024 at 07:05, 5 months 18 days ago

Valneva annonce la mise à disposition de la documentation pour son Assemblée Générale Mixte et fait le point sur l'entreprise

Assemblée Générale Valneva Mise À Jour De L'entreprise Changements À La Direction

Published on 11/22/2024 at 23:55, 19 hours 44 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 20 hours 9 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 20 hours 34 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 20 hours 34 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 21 hours 9 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 1 hour ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 1 hour ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 1 hour ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 2 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 3 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 1 hour ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 3 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 5 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 5 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 12 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News